patent/WO-03072757-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03072757-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25491274d4defd66f2903561fed16e54
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6512 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
filingDate	2003-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74b6410106eaf84078ad341f32098a4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_257776f0a6e25cf89f0eb1ad07cbf9ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abf9ce89f01ec0ee8941ff8cf4268c5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8891135e6dcf3f9d8f04b3db5f310938 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29efaa7871c82ef752e14e89f1bfb5ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6813a3593d3d348ee0977fa5a26121f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67f76d5dad521bda7e7f1812d82375c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd04a44da18868bf2865f62f26d4d923 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b41475592b45cdb8af7544f38923b459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83dfd03c6f40eaebdf747c005dbe808b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6dc3512666b40f3edea09d28d522535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fe973df03b321d22564112984ce8845
publicationDate	2004-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-03072757-A3
titleOfInvention	Nucleotide mimics and their prodrugs
abstract	The present invention relates to nucleoside disphosphate mimics and nucleoside triphosphate mimics, which contain disphosphate or triphosphate moiety mimics and optionally sugar-modifications and/or base-modifications. The nucleotide mimics of the present invention, in a form of a pharmaceutically acceptable salt, a pharmaceutically acceptable prodrug, or a pharmaceutical formulation, are useful as antiviral, antimicrobial, and anticancer agents. The present invention provides a method for the treatment of viral infections, microbial infections, and proliferative disorders. The present invention also relates to pharmaceutical compositions comprising the compounds of the present invention optionally in combination with other pharmaceutically active agents.
priorityDate	2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5177198-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5130302-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5859231-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467382934 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397645 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466980062

Total number of triples: 47.